Document is current
Any future updates will be listed below
-
Authors
Agoro, Rafiou http://orcid.org/0000-0002-5461-7685
White, Kenneth E.
- License Information
-
More Information
Article History
Accepted: 30 November 2022
First Online: 9 January 2023
Competing interests
: K.E.W. receives royalties for licensing FGF23 to Kyowa Hakko Kirin Co., Ltd., has previously received funding from Akebia and currently receives funding from Calico Labs. K.E.W. also owns equity interest in FGF Therapeutics. R.A. has no competing interests.
